Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days
Intellia Therapeutics
Intellia Therapeutics is a US biotechnology company developing innovative therapeutics using groundbreaking CRISPR/Cas9 genome editing. The company focuses on precise gene editing to treat serious medical conditions.
All Dates
Earnings history data not available
Company Information
Name
Intellia Therapeutics
Country
🇺🇸
More Financial Information